Thank You PointCross

Thanks for submitting the form. A member from PointCross Life Sciences will get in touch with you shortly regarding your request for a demo.

Check out some of our latest blog posts:

June 2024

Clinical Research Metadata Management: The Role of Xbiom by PointCross 

Table of ContentsThe Importance of Metadata Management in Clinical Research Xbiom: A Comprehensive Solution Centralized Metadata Repository Scalability and Flexibility Enhanced Data Integration Regulatory Compliance User-Friendly Interface Advanced Analytics and Reporting Security and Access Control Xbiom Functional Components: Enhancing Metadata Management 1. Metadata Repository 2. Centralized Data Repository 3. Regulatory Workflow  In the fast-paced world of clinical research, having a flexible and reliable system for managing metadata...

May 2024

Webinar on The Most Common Issues in Preparing SEND: Explained

In this webinar, we discussed how SEND-ASSURE ensures consistency with the audited Study Report, conformance to Technical Rejection Criteria guidelines, and follows details of the Technical Conformance Guide as the trusted references for data submission and regulatory compliance. Key Takeaways: The most common errors in SEND with recommendations to correct them Feedback related to submission and analysis Pinpoint QC ideas Submit...

PointCross attends Verisian first community event in Hyderabad

We're thrilled to share that our team members, Raja and Arpitha, recently had the privilege to attend Verisian's first community event in Hyderabad. During the event, we had the opportunity to present on: "Leveraging LLMs for Traceable Metadata Specifications and Executable Search Expressions in TFL & ADaM Generation." For those who couldn't make it, fret not!...

March 2024

SOT ToxExpo 2024

PointCross was present at the 2024 SOT #ToxExpo. Date: March 10–14, 2024 Salt Palace Convention Center in downtown Salt Lake City, Utah Takeaways: CROs and Sponsors love PointCross’ instant SEND quote generator, fast turnaround time, and study data visualization offering Integrating bioanalytical and complex biomarker data with as collected in-life data can be done in real time and people loved seeing subject level study details for ongoing...

February 2024

Interim Nonclinical Study Monitoring with Xbiom™ Insights 

In nonclinical studies, waiting until the completion of a study to make data-driven decisions may limit the potential for valuable insights. Traditional study reports published post-completion often lack the ability to provide on-study analysis and early indicators crucial for driving amendments and gaining deeper insights. Here comes Xbiom™ Insights, a cutting-edge interim nonclinical study...

January 2024

PHUSE US CONNECT 2024: PointCross Highlights Rapid SDTM and Compliance Dashboards

PointCross Life Sciences was thrilled by the level of interest and excitement with regards to the poster we presented at PhUSE Connect 2024, titled “Rapid SDTM and Compliance Dashboards”. We had some important dialogue with industry peers and leaders in the space pertaining to revolutionizing SDTM development in clinical research. Key Takeaways: Integration of Standards and...

SCOPE Summit for Clinical Ops Executives 2024

Date: February 11-14, 2024 Rosen Shingle Creek Orlando, FL PointCross will be at SCOPE Summit for Clinical Ops Executives 2024 in Orlando, FL, from February 11-14. Our Vice President Rahul Madhavan (Strategic Programs) and Vice President Harinarayan Gopichandran (Technical Solutions) look forward to meeting our customers on site and forming new relationships with those interested in...

Clinical Interim Study Monitoring: A Deep Dive into PointCross Xbiom™ Insights  

Introduction to Clinical Interim Study Monitoring  Clinical Interim Study Monitoring has taken a giant leap forward with PointCross Life Sciences' innovative solution, Xbiom™ Insights. In this blog post, we will explore the transformative capabilities of this platform, shedding light on its real-time integration of Electronic Data Capture (EDC) patient data and biomarker data from bio-samples....